Home > News > Crystalplex Receives $100,000 Investment
April 26th, 2004
Crystalplex Receives $100,000 Investment
Abstract:
Crystalplex, a Pittsburgh nanobiotechnology company and the Pittsburgh Life Sciences Greenhouse (PLSG),
a partnership to put the region's life sciences industry on a fast track for growth, today announced that PLSG, through its affiliate the Pittsburgh Biomedical Development Corporation (PBDC), intends to invest $100,000 in pre-seed funds to Crystalplex, an early stage company that is developing a technology that aids in drug discovery and clinical diagnostics.
Source:
PRNewswire
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanomedicine
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013